The Patent Finder

Eyetech Pharmaceuticals, Inc.

Also on record
Records under this name other than patents Eyetech Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 5 of 5 · Back to Eyetech Pharmaceuticals, Inc.

PatentTitleStatus Expires Confidence
US 8,685,397Combination therapy for the treatment of ocular neovascular disorders
Formerly held
Lapsed on the fee record
Ended Apr 1, 2022 · From the USPTO record
Lapsed on the fee recordEnded Apr 1, 2022From the USPTO record
US 8,206,707Combination therapy for the treatment of ocular neovascular disorders
Formerly held
Lapsed on the fee record
Ended Jun 26, 2020 · From the USPTO record
Lapsed on the fee recordEnded Jun 26, 2020From the USPTO record
US 8,187,597Combination therapy for the treatment of ocular neovascular disorders
Formerly held
Lapsed on the fee record
Ended May 29, 2020 · From the USPTO record
Lapsed on the fee recordEnded May 29, 2020From the USPTO record
US 7,759,472Combination therapy for the treatment of ocular neovascular disorders
Formerly held
Lapsed on the fee record
Ended Jul 20, 2018 · From the USPTO record
Lapsed on the fee recordEnded Jul 20, 2018From the USPTO record
US 7,785,784Detection of oligonucleotides by dual hybridization
Formerly held
Lapsed on the fee record
Ended Aug 31, 2014 · From the USPTO record
Lapsed on the fee recordEnded Aug 31, 2014From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited